{"id":"6987d236-be8b-4e20-b75d-253e72405417","arxiv_id":"2411.17899","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"high","formal_verification":"none","parameter_count":2,"one_line_summary":"The authors use bibliometric counts and network maps to conclude that Germany is strategically positioned in 5G/6G remote-surgery innovation, but the small sample and descriptive method do not support the strength of the claim.","lead":"This paper maps publications and patents on 5G/6G remote surgery and argues that Germany is a strategically positioned knowledge producer. The evidence is thin, based on five German papers and no statistical baseline, so the claim is stronger than the data support.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Germany's strategic-position claim rests on 5 German publications (Table 1); Table 2's 'strong' collaborators each have 1 publication, so no baseline or query validation exists to support Section 5.1's conclusion.","rationale":"Reading the paper in good faith: it is an exploratory bibliometric mapping of a nascent application domain, and the descriptive maps (Graphs 1-16) are useful as descriptive outputs. The research question (Section 1) is about capability, and the central claim is Germany's strategic position. For that claim to hold, the bibliometric indicators must be valid and sufficiently powered measures of knowledge production and diffusion for remote surgery. The weakest place is the German national sample: 5 publications and a patent table that does not reconcile with the reported 51 families. The reader's weakest assumption identified the same validity premise, and I agree. No formal verification, code, or data release offsets the small-sample fragility; the only independent markers are exploratory descriptive statistics. I therefore see no reason to adjust the REJECT verdict, though I would frame the rejection as 'insufficient evidence for the capability claim' rather than 'the bibliometric approach is invalid.'","tokens_in":20302,"tokens_out":5785,"duration_ms":51202,"concrete_test":"Perform a construct-validity and robustness check on the German corpus: (1) retrieve all WoS records from Eq. 1-A with a Germany filter; manually classify each of the resulting 5 publications by whether remote surgery/telesurgery is the actual clinical focus. (2) Run two placebo queries—identical 5G/6G block AND ('telemedicine' OR 'telehealth'), and identical block AND 'cardiology'—and build VOSviewer networks for Germany using the same thresholds. (3) Recompute Section 4.3 after deleting the single highest-citation German publication. If fewer than 3 of the 5 records are genuinely remote-surgery papers, if the German network is not distinguishable from the placebo networks, or if one-record deletion removes Germany from the network, then the Section 5.1 strategic-position claim is not supported.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim (Section 5.1) is that Germany is strategically positioned in the 5G/6G remote-surgery TIS because of its 'diverse conglomerate of enterprises from around the world, including research institutes and public organisations.' The only evidence is bibliometric: Table 1 reports 160 international publications and 5 German publications; Section 4.3's German collaboration network (Graphs 8-9, Table 2) is built from those 5 publications. Table 2's top 'strong performance' organizations—Chinese PLA General Hospital, Jingzhou Central Hospital, Medical School of Chinese PLA, and University of Erlangen-Nuremberg—each have exactly 1 publication and total link strengths of 3; Ericsson Research, Huawei Technologies Düsseldorf, TU Munich, and Karlsruhe have 1 publication with link strengths 1, 1, 1, and 0. With n=5, the network's edges are individual co-authorship events, so 'strategic alignment' (Section 4.3) is not a measured TIS structure. There is no baseline (e.g., comparable mid-sized economies), no null model, and no validation that Eq. 1-A retrieves remote-surgery-specific records rather than any 5G/6G-plus-surgery paper. The 51 German patents do not rescue the claim: Section 4.5's assignee graph lists only 12 patent families (NVIDIA 5, Skyworks 4, Apple 1, HPE 1, Skyworks Global 1), unreconciled with Table 1's 51, and Table 5's domestic institutions report relationship documents, not German patent families. The conclusion is thus underdetermined by the evidence; this is an internal evidence-strength problem, not a dispute about bibliometric methods.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The manuscript applies a Technological Innovation Systems (TIS) framework to bibliometric data on 5G/6G remote surgery, combining Web of Science publication records and Orbit patent families with VOSviewer network maps. It reports 160 international and 5 German publications, and 5,704 international and 51 German patent families, and it claims that Germany is a strategically positioned actor in the 5G/6G remote-surgery TIS because of its international conglomerate of enterprises, research institutes, and public organizations. The paper concludes by proposing policies to connect smaller suppliers with larger firms in Germany.","tokens_in":20628,"tokens_out":4828,"duration_ms":43038,"significance":"If the central claim were supported, the paper would provide a useful empirical illustration of how TIS functions 2 and 3 can be measured for an emerging medical-telecommunication application, and it would offer a policy-relevant national case study. The manuscript deserves credit for making its publication search query explicit in the appendix and for using standard bibliometric network tools, which aids transparency. However, the evidence base is far too thin for the stated conclusion: the German publication sample has five records, the 'strong' collaboration organizations each have one publication, and the patent counts are internally inconsistent. As it stands, the manuscript is a descriptive bibliometric exercise rather than a demonstrated account of Germany's strategic position.","major_comments":[{"comment":"The eight organizations described as showing 'strong performance' in German collaborations each have exactly one publication, and their reported total link strengths range from 3 to 0. With a national sample of only 5 publications, the edges in Graph 9 are individual co-authorship events, so labels such as 'strong academic-industrial partnerships' and 'strategic alignment' are not supported by any measured TIS structure. No null model, baseline, or comparison with other mid-sized economies is provided, so the table cannot bear the interpretive weight placed on it in Section 5.1.","section":"Section 4.3, Table 2"},{"comment":"The 51 German patent inventions reported in Table 1 are not reconciled with Graph 15, which lists only 12 patent families among German assignees (NVIDIA 5, Skyworks 4, Apple 1, Hewlett Packard Enterprise Development 1, Skyworks Global 1). Table 5 reports 'relation documents' rather than patent families, so it does not fill the gap. The patent evidence for Germany's strategic position is therefore not reproducible as reported, and the discrepancy undermines the quantitative foundation of the paper.","section":"Section 4.5, Table 1"},{"comment":"The publication query in Eq. 1-A is a broad AND-combination of 5G/6G terms with surgery-related terms, but Eq. 2-B is empty in the manuscript, so the patent search strategy is not reported. There is no precision or recall validation demonstrating that the retrieved records concern remote surgery as opposed to any 5G/6G telecommunications document that incidentally mentions surgery. Because the central empirical claims depend entirely on these counts, the missing patent query and the absence of validation are load-bearing gaps.","section":"Section 3.1 and Appendix"},{"comment":"The discussion of Graph 6 states that Germany does not appear in the international collaboration map because it has no international collaborations, yet Section 5.1 concludes that Germany is 'strategically positioned' in the international TIS because of its 'diverse conglomerate of enterprises from around the world'. These two statements are in tension and need to be reconciled; as written, the absence of international co-authorship contradicts the claim of international strategic positioning rather than supporting it.","section":"Section 4.2 and Section 5.1"},{"comment":"The central claim that Germany is a strategic actor in 5G/6G remote surgery is underdetermined by five national publications and unreconciled patent counts. Section 6 concedes that future studies should 'overcome many limitations', but the manuscript never states the small-sample limitation explicitly and offers no external validation, such as evidence of clinical deployments, surgical trial activity, or network infrastructure for remote surgery. The conclusion in Section 5.1 should be substantially qualified to an exploratory hypothesis, or supported with additional evidence of the type just listed.","section":"Sections 4.3 and 5.1"}],"minor_comments":[{"comment":"The phrase 'This paper is a comprehensive exploring of technology capability' is ungrammatical; it should read 'comprehensive exploration'.","section":"Abstract"},{"comment":"Exhibit references are inconsistent: Section 4.3 says 'Table 3 provides part of these organisations' when the displayed table is Table 2, and Section 4.5 refers to 'Graphic 18 and Table 7' when the exhibits shown are Graph 15, Graph 16, and Table 5.","section":"Sections 4.3 and 4.5"},{"comment":"The footnote 'See Schmidt & Dabur's status in item 2.4.1' points to a nonexistent section, and the Schmidt and Dabur reference is incomplete in the reference list.","section":"Section 3.2 footnote and references"},{"comment":"The time window is described as 2016-2024 in Table 1, but the text around Graph 1 refers to patent activity beginning in 2014 and a post-2010 surge; the start year should be reconciled.","section":"Table 1 and Graph 1"},{"comment":"Several listed references, such as the IEEE Standards Association, ISO, and ITU entries, are not cited in the body text, and some in-text citations do not have complete entries; the manuscript would benefit from thorough copyediting and reference checking.","section":"Reference list"}],"recommendation":"reject","confidential_remarks":"The manuscript addresses a topical question and has a transparent publication query, but the evidentiary gap is fundamental: the German strategic-position claim rests on five publications, and the patent evidence is internally inconsistent. I do not see a way to repair the central claim within the current scope without either new data or a major reframing of the contribution as a purely descriptive pilot, which would fall short of the paper's stated ambitions. I therefore recommend rejection rather than major revision."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Quick take: this is a bibliometric application of the TIS framework to 5G/6G remote surgery, with useful global maps but a German-case conclusion that the data can't carry. I agree with the reader's reject verdict, though I'd say the paper is a solid desk reject rather than a deeply flawed one.\n\nWhat's actually here: the authors define their search queries (Appendix Eq. 1-A), pull WoS and Orbit data, and build VOSviewer networks for international and national levels. The global maps (publications by country, patent assignees, citation-impact table) are a legitimate descriptive exercise and could be a starting point for someone new to this niche. Using TIS Functions 2 and 3 explicitly is fine. The paper is readable and the conceptual framing is not nonsensical.\n\nThe problem is the gap between evidence and claim. The German national sample is five publications; Table 2's top collaborators each have one publication and three or four citations. Calling those 'strong academic-industrial partnerships' or 'strategic alignment' is not defensible. With n=5, the network edges are individual co-authorship events, not a structure. There's no baseline, no null model, no validation that the query retrieves remote-surgery-specific records as opposed to any 5G-plus-surgery paper. The patent side doesn't rescue it: Table 1 says 51 German inventions, but Graph 15 lists 12 patent families (NVIDIA 5, Skyworks 4, Apple 1, HPE 1, Skyworks Global 1), and Table 5 reports relation documents, not families. That internal inconsistency matters.\n\nI also share the novelty concern. The authors' own Martinelli et al. (2024) is the same German case, and this version doesn't state what's genuinely new. That's not a citation-pattern sin per se, but it makes the 'strategic actor' conclusion look like it was already committed.\n\nMinor issues: incomplete references (e.g., 'Rickap' vs Rikap, the dangling Schmidt & Dabur footnote), and some graph/table numbering is sloppy. These are fixable but secondary.\n\nWho gets value: someone wanting a quick descriptive map of 5G/6G remote-surgery publications and patents, not someone making policy off the German claims. I wouldn't cite it in my own work. I would not send this to referees — the central claim is underdetermined by the reported evidence, and a revision would need substantial new data or a much more modest claim. If the authors reframe it as an exploratory bibliometric snapshot, it might be worth a short paper somewhere; as is, desk reject.","headline":"A tidy bibliometric exercise whose central claim about Germany rests on five publications; the global maps have exploratory value, but the German strategic-position conclusion is not supported by the reported data.","tokens_in":21213,"tokens_out":3127,"would_cite":false,"duration_ms":27754,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":false},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Bibliometric evidence places Germany as a strategic, though not dominant, actor in 5G/6G remote-surgery technology.","keywords":["5G/6G networks","remote surgery","Technological Innovation Systems","bibliometrics","knowledge production","knowledge diffusion","Germany","patents"],"falsifier":"Re-run the publication and patent searches with somewhat broader application terms, such as telemedicine, telesurgery, or haptic feedback, and in a different patent database; if Germany's 5-publication/51-patent footprint disappears or its collaboration links break, the strategic-position conclusion is an artifact of query and database choices.","tokens_in":20059,"feed_emoji":"🏥","tokens_out":12854,"duration_ms":106678,"temperature":0.7,"pith_summary":"The paper asks how capability in 5G/6G networks for remote surgery is produced and diffused globally and in Germany, and answers with a bibliometric study of publications, patents, and collaboration networks read through the Technological Innovation System (TIS) framework. Its central claim is that Germany, without being a dominant player, is strategically positioned in the international 5G/6G TIS for remote surgery because its territory hosts a diverse mix of foreign enterprises, research institutes, and public organizations that generate and exchange relevant knowledge. Globally, the paper finds China leading in patent quantity, while a small set of non-Chinese companies, including Cilag International, Ericsson, Ethicon, and Strong Force VCN Portfolio 2019, hold the most citation-impacted patents. From this reading the paper proposes policies that connect smaller German suppliers with larger companies able to act as intermediaries and open international markets, on the assumption that knowledge production and network formation are the functions that drive a young technology's trajectory.","feed_headline":"Bibliometrics cast Germany as a strategic 5G remote-surgery player","feed_subtitle":"A trail of just 5 publications and 51 patents, plus foreign tech firms' local research, underpins Germany's position.","key_machinery":"The central machinery is the Technological Innovation System (TIS) framework, defined as the actors, institutions, networks, and technologies that jointly generate a technology and move it toward use; within it, the paper works with Functions 2 and 3, knowledge production and knowledge diffusion/network formation. Those functions are operationalized as bibliometric indicators: publication counts, patent-family counts, average citation impact, and collaboration-network maps of co-authorship and co-patenting. These indicators carry the argument by converting the abstract idea of national technological capability into a visible map of which organizations publish together, which firms hold high-impact patents, and which hubs anchor a country's innovation system.","core_discovery":"The core discovery is stated in Section 5.1: Germany, while not a dominant player, has been strategically positioned in the industrial application of 5G/6G networks for remote surgery because of its diverse conglomerate of enterprises from around the world, including research institutes and public organizations. The international patent picture is led in quantity by Chinese firms, above all Huawei and Xiaomi, but the patent families with the greatest citation impact belong to Cilag International, Ericsson, Ethicon, and Strong Force VCN Portfolio 2019, which the authors read as evidence that counting patents alone misreads the TIS. Germany enters the analysis with a small national sample, 5 publications and 51 patent inventions, yet its collaboration networks link German universities and research centers with foreign industrial actors such as Huawei, Ericsson, NVIDIA, and Skyworks. The authors interpret this as a national TIS that produces knowledge through internal, often EU-linked collaborations and diffuses it through foreign-owned local presence rather than through international publication co-authorship.","pith_inferences":["Inference: the bibliometric signal may understate German capability because much relevant know-how sits inside foreign multinationals' local R&D units; a direct test would be to count German-origin inventions within foreign-owned patent portfolios separately from domestic assignees.","Inference: Germany's sparse international co-authorship could reflect funding structures or industrial secrecy rather than weak global integration; co-patenting with foreign firms would test diffusion more directly than co-authorship.","Inference: the paper's global pattern suggests a transferable lesson for other emerging technologies: citation-weighted patent analysis should be paired with deployment or clinical-adoption data before drawing conclusions about which countries matter.","Inference: with 6G standards still forming, the high-citation patent holders identified here are plausible contributors to future standard-essential patents; tracking declarations of standard-essential patents would test whether citation impact converts into standard-setting power."],"forward_implications":["If correct, Germany's 5G/6G remote-surgery capability is concentrated in identifiable hubs, including Munich, Berlin, Düsseldorf, Tübingen, Heidelberg, and Leipzig, and anchored by institutions such as the Technical University of Munich, Fraunhofer-Gesellschaft, Charité, and university hospitals.","Knowledge diffusion in Germany follows mainly national and European links, so proximity to foreign multinationals located in Germany matters more than international publication collaboration for technology transfer.","Policy that pairs smaller German suppliers with large firms as intermediaries is the paper's concrete lever for turning domestic knowledge production into participation in international markets.","At the global level, patent leadership and citation impact point to different actors, so technology policy based on patent counts alone would misidentify the strategically relevant players in the TIS.","Because 6G is presented as an evolution of 5G, the knowledge-production and network patterns mapped for the current system are the ones expected to shape the next generation of remote-surgery applications."],"supporting_citations":[{"why":"Supplies the TIS functions framework, including the knowledge production and diffusion functions the paper uses.","marker":"Hekkert et al. (2007)"},{"why":"Provides a prior national-level application of TIS functions that the paper adapts to the German case.","marker":"Furtado et al. (2020)"},{"why":"Defines the problem of TIS in contexts, which motivates the paper's separation of international and national levels.","marker":"Bergek et al. (2015)"},{"why":"Connects TIS to geographical contexts and to national/international levels, grounding the two-level analysis.","marker":"Binz & Truffer (2017)"},{"why":"Establishes publications, patents, and standards as observable channels of knowledge and technology transfer in a TIS.","marker":"Ashari et al. (2023)"},{"why":"Documents which organizations are active in 5G publishing, patenting, and standardization, informing the patent analysis.","marker":"Buggenhagen & Blind (2022)"},{"why":"Supports the claim that technological system boundaries do not coincide with national boundaries, justifying an international TIS view.","marker":"Carlsson & Stankiewicz (1991)"}],"fun_headline_variants":["Germany's 5G surgery edge comes from foreign firms' local research","Small German sample, big strategic role in 5G remote surgery","Patent counts mislead: Germany's 5G surgery role is strategic","Germany's small 5G surgery footprint belies strategic role"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"That bibliometric counts and collaboration-network maps are valid and sufficient measures of knowledge production and diffusion in the 5G/6G remote-surgery TIS, so that a national sample of 5 publications and 51 patents can establish Germany's strategic position.","fun_headline_variants_meta":{"raw":{"variants":["Germany's 5G surgery edge comes from foreign firms' local research","Small German sample, big strategic role in 5G remote surgery","Patent counts mislead: Germany's 5G surgery role is strategic","Germany's small 5G surgery footprint belies strategic role"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.00046,"raw_usage":{"total_tokens":2272,"prompt_tokens":882,"completion_tokens":1390,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":498,"completion_tokens_details":{"reasoning_tokens":1314}},"tokens_in":498,"tokens_out":1390,"duration_ms":9098,"temperature":1.0,"reasoning_tokens":1314,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-12T11:43:15.188018+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Re-run the publication and patent searches with somewhat broader application terms, such as telemedicine, telesurgery, or haptic feedback, and in a different patent database; if Germany's 5-publication/51-patent footprint disappears or its collaboration links break, the strategic-position conclusion is an artifact of query and database choices.","supporting_citations":[],"review_version":1}